Safety, pharmacokinetics and anti-tumor activity of RP12146, a PARP1/2 inhibitor, in patients with locally advanced or metastatic solid tumors.

被引：0

作者：

Wysocki, Piotr Jan

Lubas, Maciej Tadeusz

Lobacz, Mateusz

Kalinka-Warzocha, Ewa

Tomczak, Piotr

Kwiatek, Michal

Lugowska, Iwona A.

Smakal, Martin

Chraniuk, Dominik

Melichar, Bohuslav

Markiewicz-Bialek, Beate

Routhu, Kasi V.

Barde, Prajak J.

Nair, Ajit

机构：

[1] Jagiellonian Univ Hosp, Krakow, Poland

[2] Krakow Univ Hosp, Krakow, Poland

[3] Polish Mothers Mem Hosp, Res Inst, Warsaw, Poland

[4] Pratia Poznan Med Ctr, Poznan, Poland

[5] Maria Sklodowska Curie Natl Res Inst & Oncol Ctr, Warsaw, Poland

[6] Multiscan Sro, Prague, Poland

[7] Clin Trials Site Nasz Lekarz, Torun, Poland

[8] FNOL Oncol Clin, Olomouc, Poland

[9] Centrum Med Medyceusz, Lodz, Czech Republic

[10] Rhizen Pharmaceut AG, Basel, Switzerland

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3097

引用

页数：1